cms_ND: 87
Data source: Big Local News · About: big-local-datasette
rowid | facility_name | facility_id | address | city | state | zip | inspection_date | deficiency_tag | scope_severity | complaint | standard | eventid | inspection_text | filedate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
87 | MINOT HEALTH AND REHAB, LLC | 355031 | 600 S MAIN ST | MINOT | ND | 58701 | 2018-08-16 | 756 | D | 0 | 1 | B0I611 | **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, review of facility policy, and staff interview, the consulting pharmacist failed to identify and report drug regimen irregularities regarding duplicate therapy of opiate pain medications to the attending physician, the medical director, and the director of nursing for 1 of 18 sampled residents (Resident #35) reviewed. Failure to ensure the pharmacist reported the medication irregularities may result in the residents receiving unnecessary medications and experiencing adverse consequences related to the medications. Findings include: Review of the facility policy titled Consultant Pharmacist Reports occurred on 08/16/18. This policy, dated (MONTH) 2011, stated, . The administration schedule is appropriate for the resident, considering side effects (such as sedation), compatibility with other medications and manufacturer's recommendations. Resident #35's record identified the following physician's orders for opiate pain medications: [REDACTED] * 04/05/18: [MEDICATION NAME] 50 milligrams (mg) by mouth three times a day for uncontrolled pain * 04/13/18: [MEDICATION NAME]-[MEDICATION NAME] 5-325 mg one tablet by mouth four times a day for pain Review of the resident's Medication Administration Record [REDACTED]. This schedule resulted in the resident receiving two opiate medications at 8:00 a.m. and at 8:00 p.m. each day. During an interview on 08/16/18 at 11:00 a.m., an administrative nurse (#16) reported she was unable to locate any Pharmacy reviews pertaining to either of these two pain medications. | 2020-09-01 |